Landmark cardiac xenotransplantation procedure conducted at University of Maryland Medical Center Tegoprubart, administered investigationally to prevent organ rejection post-transplant, targets...
Read moreDetailsSherman Edmiston III and Richard J. Salute bring extensive technology, accounting, and business expertise to Near’s Board of DirectorsPASADENA, Calif.,...
Read moreDetailsProlonged life with 49% decreased risk of death for participants in the HEALEY ALS Platform Trial treated with CNM-Au8® 30mg...
Read moreDetailsCAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through...
Read moreDetailsBOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing...
Read moreDetailsFORT LAUDERDALE, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) -- SEACOR Holdings Inc. (“SEACOR”) announced today the sale of its U.S....
Read moreDetailsating consumers’ motivation, preferred resources and influencers on their decisions about cosmetic procedures, provider type and skin care purchases. 2023...
Read moreDetailsApproval triggers $1.5 million milestone payment to CaraSTAMFORD, Conn., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a...
Read moreDetailsSAN DIEGO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that...
Read moreDetailsMETTAWA, Ill., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC), the world’s largest recreational marine technology company, today...
Read moreDetails